The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor
Yuan Yang(Central South University), Lihui Wang(Genedata (Switzerland))
Cited by 9
Related Papers
Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity
|Cell Death and Disease|2017|134
Inactivation of <i>SMAD4</i> Tumor Suppressor Gene During Gastric Carcinoma Progression
|Clinical Cancer Research|2007|111
Core–Shell–Shell Multifunctional Nanoplatform for Intracellular Tumor-Related mRNAs Imaging and Near-Infrared Light Triggered Photodynamic–Photothermal Synergistic Therapy
|Analytical Chemistry|2017|72
An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer
|Molecular Cancer|2022|62
<p>LINC00565 promotes proliferation and inhibits apoptosis of gastric cancer by targeting miR-665/AKT3 axis</p>
|OncoTargets and Therapy|2019|25